An Educational Opportunity for Clinicians Specializing in the Treatment of
Multiple Sclerosis

FACULTY AND PLANNING COMMITTEE AFFILIATIONS AND DISCLOSURES

 

Chair

Stephen Krieger, MD 
Assistant Professor of Neurology
Mount Sinai School of Medicine
Attending Neurologist
Corinne Goldsmith Dickinson Center for MS
Mount Sinai Medical Center
New York, New York

Faculty

Erik Burton, MD
Assistant Professor of Neurology
University of New Mexico
Albuquerque, New Mexico

Constance Easterling, MSN
Clinical Coordinator/Nurse Practitioner
Neurological Services
Orlando, Florida

Patricia Kennedy, BSN, RN, CNP, MSCN
Nurse Educator
Can Do Multiple Sclerosis
Edwards, Colorado

Fred Lublin, MD 
Saunders Family Professor of Neurology
Mount Sinai School of Medicine
Director, Corinne Goldsmith Dickinson Center for MS
Mount Sinai Medical Center
New York, New York

Robert Naismith, MD 
Assistant Professor of Neurology
Washington University
St. Louis, Missouri

Amy Perrin Ross, MSN 
Neuroscience Program Coordinator
Loyola University Chicago
Maywood, Illinois

Planning Committee

Tarra Barot, PhD, The Academy for Continued Healthcare Learning, Senior Medical Writer
Mindi Daiga, MBA, The Academy for Continued Healthcare Learning, Director of Compliance and Outcomes Management
Katie Hacias, The Academy for Continued Healthcare Learning, Associate Program Director
Lisa Keckich, The Academy for Continued Healthcare Learning, Executive Director
June Halper, MSN, APN-C, MSCN, FAAN, Consortium of MS Centers
Nicole Liloia, LCSW, Consortium of MS Centers
Laurie Scudder, DNP, NP, Nurse Practitioner Alternatives

Reviewer: Laurie Scudder, DNP, NP, Nurse Practitioner Alternatives. Please note that content was developed in conjunction with the faculty, CMSC, NPA, and the scientific team at ACHL.

DISCLOSURES

Current guidelines require that participants in CME/CE activities be made aware of all affiliations or financial interests that may be perceived as influencing the content of an educational activity. The Academy for Continued Healthcare Learning (ACHL), Consortium of MS Centers and Nurse Practitioner Alternatives, ensures that all faculty and staff involved in the planning, development, and implementation of this activity disclose all potential conflicts of interest and resolve them before the CME/CE activity occurs. Disclosures are provided below:

Faculty Disclosures

Erik Burton, MD
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents:
Genzyme; Novartis

Constance Easterling, MSN, ARNP, MSCN
Consulting Fees:
Acorda Therapeutics; EMD Serono; Pfizer; QuestCor
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents: Acorda Therapeutics; EMD Serono; Bayer HealthCare; Biogen Idec; Pfizer; Teva Neuroscience; QuestCor

Patricia Kennedy, BSN, RN, CNP, MSCN
Consulting Fees:
Acorda Therapeutics; EMD Serono; Novartis; sanofi-aventis
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents: Acorda Therapeutics; EMD Serono; Novartis; sanofi-aventis

Stephen Krieger, MD
Consulting Fees:
Acorda Therapeutics; Bayer HealthCare; Genzyme; Novartis; QuestCor
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents: Teva Neuroscience
Contracted Research: Bayer HealthCare

Fred Lublin, MD
Consulting Fees:
Acorda Therapeutics; Actelion; Bayer HealthCare; Biogen Idec; Bristol-Myers Squibb; Celgene; Coronado Bioscience; EMD Serono; Genentech; Genzyme; Johnson & Johnson; Novartis; MedImmune; Pfizer; QuestCor; Revalesio; Roche; sanof-aventis; Teva Neuroscience;
Contracted Research: Acorda Therapeutics; Biogen Idec; Celgene; Genzyme; NIH; NMSS; Novartis; sanofi-aventis; Teva Neuroscience
Ownership Interest: Cognition Pharmaceuticals, Inc.
Other (co-chief editor): Multiple Sclerosis and Related Diseases

Robert Naismith, MD
Consulting Fees:
Acorda Therapeutics; Biogen Idec; Genzyme; Teva Neuroscience
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents: Acorda Therapeutics; Bayer HealthCare
Contracted Research: Acorda Therapeutics; Roche; National Multiple Sclerosis Society
Other (speaking for organizations): National Multiple Sclerosis Society; Consortium of MS Centers

Amy Perrin Ross, MSN
Consulting Fees: 
Acorda Therapeutics; Allergan; Bayer HealthCare; EMD Serono; Genzyme; Novartis; Pfizer; Teva Neuroscience
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents:Acorda Therapeutics; Allergan; Bayer HealthCare; EMD Serono; Genzyme; Novartis; Pfizer; Teva Neuroscience

Planning Committee Disclosures

The Academy for Continued Healthcare Learning and Nurse Practitioner Alternatives staff members and others involved with the planning, development, and review of the content for this activity have disclosed that there are no relevant affiliations or financial relationships.

June Halper, MSN, ANP, FAAN
Consulting Fees: Acorda Therapeutics
Fees for Non-CE Services Received Directly from Commercial Interest or their Agents: Acorda Therapeutics

Nicole Liloia, LCSW No relevant affiliations or financial relationships to disclose.

Participation

Participation is open to healthcare professionals who treat patients with MS. Release Date: March 25, 2013 | Expiration Date: March 25, 2015